Reddy NS*, Ramanjaneyulu K, Sabbani V and Choday V
Department of Pharmacology, Vishnu Institute of Pharmaceutical Education and Research, Vishnupur, Narsapur, Medak, Telangana, India
Received date: April 03, 2017; Accepted date: June 06, 2017; Published date: June 12, 2017
Citation: Reddy NS, Sabbani V, Choday V (2017) In Vitro and in Vivo Antidiabetic Activity of Rumex Vesicarius Leaves Extract in Streptozotocin Induced Diabetic Albino Wister Rats. J Diabetes Metab 8:745. doi: 10.4172/2155-6156.1000745
Copyright: © 2017 Reddy NS, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Visit for more related articles at Journal of Diabetes & Metabolism
Objective: The principle goal of this work is to assess the in vitro and in vivo antidiabetic activity of ethanolic extract of Rumex vesicarius in the streptozotocin actuated diabetic rats. Methods: Single intraperitoneal injection (i.p.) of streptozotocin (60 mg/kg body weight) was used for induction of diabetes in albino rats. The induction of diabetes was confirmed after 3 days of streptozotocin injection and rats with fasting blood glucose levels were greater than 200 mg/dl and were considered to be diabetic used in the experiment. Rumex vesicarius at a once daily dose of 100 mg/kg, 200 mg/kg and 400 mg/kg along with Glibenclamide 10 mg/kg was also given for 1 week. On the last day, the blood was collected from all groups of rats which have fasted overnight by puncturing the retro-orbit of the eye under mild ether anesthetic condition. Results: The statistical data indicated that the different doses of Rumex vesicarius significantly decrease the level of blood glucose in streptozotocin induced rats. This result indicated that Rumex vesicarius can protect pancreatic β-cells from streptozotocin induced damage which is confirmed by the results of histopathological examination of pancreas. Conclusion: Our investigation has clearly indicated that ethanolic extract of Rumex vesicarius showed antihyperglycemic activity due to its possible systemic effect involving in pancreatic mechanism.
Rumex vesicarius ; Alpha glucosidase; Glibenclamide; Diabetes; Histopathology; Pancreas; Albino Rats
Rumex vesicarius Linn. (Polygonaceae) is commonly called as Chukka kura in Telugu, Chukra in Hindi, Bladder Dock in English . Rumex vesicarius L. is a wild edible plant used as a sorrel and collected in spring season and eaten fresh or cooked. Rumex vesicarius L. has many important medicinal uses such as treatment of hepatic diseases, bad digestion, diurectic, laxative, tonic, analgesic, purgative and antibacterial agents. The plant can be used to reduce biliary disorders and control cholestrol levels [2-7]. Diabetes mellitus is the sixth leading cause of death globally . Many of the drugs have been used in the management of this disease. These drugs have many side effects and a search for new class of compounds is essential to overcome diabetic problems . Traditionally, a number of plants have been used in various herbal preparations in the management of diabetes and only few of them have been proven scientifically .
Rumex vesicarius leaves were collected from Narsapur, Medak district and authenticated by D. Venkateshwara Rao, Deputy Director, A.P. Forest Academy, Dulapally, Hyderabad, Rangareddy District.
Preparation of extracts
The collected aerial parts of the plant were washed and dried under the shade. Around 500 g of the coarsely powdered aerial parts of the plant was packed in a soxhlet apparatus and extracted with ethanol.
Albino Wistar rats (weighing 150-200 g) of both sexes, were procured from NIN, Hyderabad, India and were housed in standard metal cages. They were provided with food, water & ad libitium and allowed a one week acclimatization period prior to the study. The protocol was approved by Institutional animal ethical committee of VIPER, Narsapur Medak and the study was performed according to the CPCSEA guidelines (1358/ac/10/CPCSEA).
In vitro antidiabetic activity
In vitro α-glucosidase inhibition study: The tissue homogenate prepared from small intestine of rats was used as enzyme source. A small piece of small intestine was taken out in precooled phosphate buffer saline (PBS), thoroughly cleaned, dried on blotting paper, weighed and then homogenized in glass Teflon homogenizer. The homogenate was centrifuged at 5,000 rpm for 30 min and its supernatant was used as enzyme source. Final volume of supernatant was maintained to 20% (w/v). The spectrophotmetric assay method was used with slight modification. Here, 40 μl tissue homogenate was mixed with (1-9 mg/ml) test, standard, drug vector and incubated for 37°C. Thereafter, 280 μl maltose (37 mM) was added and further incubated for 30 min. Finally, the reaction was stopped by placing the tubes in boiling water for 10 min. Glucose concentration was assessed using Accu-chek active.
Experimental Induction of Diabetes: Streptozotocin was freshly dissolved in 0.1 M fresh cold citrate buffer pH 4.5 and maintained on ice prior to use . Diabetes was induced in overnight fasted rats by single intraperitoneal injection of streptozotocin (60 mg/kg), all animals were given free access to food and water. Blood glucose levels were measured 3 days after the streptozotocin injection and rats with fasting blood glucose levels greater than 200 mg/dl were considered to be diabetic used in the experiment.
5 groups of rats were used to study the effect of ethanolic leaf extract of Rumex vesicarius . Each group consists of 6 rats.
Group I: 5 ml of 1%gum acacia suspension.
Group II: Diabetic rats were treated with ethanolic leaf extracts of Rumex 100 mg/kg.
Group III: Diabetic rats were treated with ethanolic leaf extracts of Rumex 200 mg/kg.
Group IV: Diabetic rats were treated with ethanolic leaf extracts of Rumex 400 mg/kg.
Group V: Diabetic rats were treated with Glibenclamide 10 mg/kg body weight.
Treatment of experimental animals with ethanolic extract was initiated 3 days post streptozotocin injection and was carried out daily by oral gavage for 7 days; food and water were made freely available. The blood glucose levels were determined by using Glucometer and the values of sample were compared with Glibenclamide. After the experimental regimen, the animals were sacrificed by cervical dislocation under mild ether anesthesia. The pancreas were exposed and perfused with cold saline and phosphate buffer of pH 7.4 for histopathological examination.
In vitro antidiabetic activity
In vitro α-glycosidase inhibition activity: Rumex vesicarius showed a significant inhibitory action on α-glucosidase enzyme. The percentage inhibition at 1-9 mg/ml concentrations of Rumex vesicarius leaf extract showed a concentration dependent increase in the percentage inhibition. Rumex showed 59% inhibition at 9 mg/ml and Acarbose showed 83% inhibition. The values are tabulated in Table 1. The inhibition of alpha glycosidase enzyme by the Rumex plant in the present study provides a strong biochemical basis for the management of diabetes.
|Plant Extract (mg/ml)||% of inhibition|
Table 1: In vitro α-glucosidase inhibition of Rumexvesicarius.
In vivo antidiabetic activity
A marked rise in fasting blood glucose levels were observed in diabetic group when compared with normal control rats. Ethanolic extract of Rumex vesicarius at (100, 200, 400 mg/kg) exhibited a dose dependent significant antidiabectic activity. All the values were shown in the Table 2. It was found that ethanolic extract at 400 mg/kg showed highly significant decrease in the blood glucose levels when compared to the control STZ induced diabetic animals which was compared with the standard drug Glibenclamide (10 mg/kg). The standard drug Glibenclamide stimulates insulin secretion from of islets of Langerhans.
|Treatments||Dose mg/kg||Blood glucose levels (mg/dL) in days|
|Control %gum acacia||5ml||205±1.2||200±1.1||201±1.4||200±2.0||200±2.1|
Table 2: Effect of leaf extracts of Rumex vesicarius on blood glucose level ofstreptozotocin -induced diabetic rats during prolonged treatment.
From this study it is suggested that the possible mechanisms by which the plant extract decrease the blood glucose levels may be potentiation of insulin effect either by increase in pancreatic secretion of insulin from beta cells of Islets of Langerhans. The pancreas of Albino rats shown in Figure 1 Shows normal architecture of the pancreatic lobe disrupted fibrous tissue between the lobes when treated with 400 mg/kg of rumex extract. The Figure 2 shows the necrosis of the islet cells. Pancreatic lobes are elongated and Figure 3 shows the degranulation and Vacuolization of beta cells and almost the complete recover of cells (Figure 4) when treated with the standard drug Glibenclamide.
Histopathological Examination: The antidiabetic activity was confirmed through the histopathological pancreas of albino rats. For histopathological study the pancreas was removed after desection of rats and they were preserved in 10% Formalin. They were given for hispothalogical studies.
We would like to thank our Chairman, A Ramesh, Principal and Sabbani S, VIPER, Narsapur, Medak for providing the facilities.